Home › NDC Lookup › Ingredients › Guaifenesin › 46122-0814-04
Good Neighbor Pharmacy Mucus ER guaifenesin 1200 mg Tablet, Multilayer, Extended Release — NDC 46122-0814-04 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Good Neighbor Pharmacy Mucus ER guaifenesin 1200 mg Tablet, Multilayer, Extended Release — NDC 46122-814-04 (Billing 46122-0814-04)

by Amerisource Bergen · 2 BLISTER PACK in 1 CARTON / 7 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of Good Neighbor Pharmacy Mucus ER guaifenesin 1200 mg Tablet, Multilayer, Extended Release from Amerisource Bergen, marketed since Jun 2025 and currently FDA-listed; retail pharmacies pay about $0.4316 per unit (NADAC). It is this product's only package size.

NDC 46122-0814-04
🏷️ FDA NDC (as labeled) 46122-814-04 billing pads the product segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 46122-814-04
Product NDC 46122-814
11-digit billing NDC 46122081404
NCPDP billing unit EA — each (per item)
RxCUI 310621
UNII 495W7451VQ
Application # ANDA078912
SPL Set ID 5810b584-bbfa-4dd2-b237-71520a214c09
Established class (EPC) Expectorant
Physiologic effect Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-06-17
Route ORAL
Dosage form TABLET, MULTILAYER, EXTENDED RELEASE
Substance GUAIFENESIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43200010007450
GCN Seq No 063103
GCN 98863
HICL code 000271
Ingredient (HICL) Guaifenesin
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3J
Therapeutic class — specific (HIC3) Expectorants
AHFS code 48:16.00.00
AHFS class Expectorants
FDB label name GNP MUCUS ER 1,200 MG TABLET
FDB brand name Mucus Er
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 063103
  • GCN: 98863
  • GPI-14 (Medi-Span): 43200010007450
  • HICL (First Databank): 000271
  • AHFS class code: 48:16.00.00
  • RxCUI (RxNorm): 310621
Why two NDCs? The FDA registers this code as 46122-814-04 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0814-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Expectorant class.

Pharmacologic class Expectorant
Drug family (ATC) Expectorants
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name GNP MUCUS ER 1,200 MG TABLET Ingredient Guaifenesin
📖 What it is MedlinePlus · NLM

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Guaifenesin doesn't suppress your cough — it actually makes it work better. It loosens and thins the mucus in your chest so your cough can move it out of your airways more effectiv...
  • What exactly does guaifenesin do — does it actually stop my cough?
  • No — extended-release tablets like 12 Hour Mucus Relief and 365 Whole Foods Market Guaifenesin must be swallowed whole. Crushing, chewing, or breaking them releases the medicine al...
  • Can I crush or split the extended-release tablet to make it easier to swallow?
📖 Read our full Guaifenesin guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.432 $6.04 / 14 tablets
Medicaid paysCMS SDUD · 12 mo $0.7769 $10.88 / 14 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.449 $0.404
Flat over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
46122-0814-04 You're viewing this Main listing 2 BLISTER PACK in 1 CARTON / 7 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK 2025-06-17 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Mucus Relief ER 1200 mg 00536-1249-71 Rugby 14 tablets $0.432 — Availability likely —
Rugby Mucus Relief ER 1200 mg 00536-1451-88 Rugby 7 tablets $0.432 — Availability likely —
good neighbor pharmacy mucus er 1200 mg 46122-0683-74 Amerisource 1 tablet $0.432 — Discontinued —
Good Neighbor Pharmacy Mucus ER 1200 mgthis 46122-0814-04 Amerisource 7 tablets $0.432 — Availability likely —
Leader Mucus Relief 1200 mg 70000-0721-01 Cardinal 7 tablets $0.432 — Availability likely —
Mucus Relief 1200 mg 70000-0730-01 LEADER/ 14 tablets $0.432 — Availability likely —
Mucus Relief 1200 mg 70677-1051-01 Strategic 1 tablet $0.432 — Availability likely —
Guaifenesin 1200 mg 70677-1258-01 Strategic 14 tablets $0.432 — Availability likely —
Mucus Relief 1200 mg 83324-0096-14 CHAIN 14 tablets $0.432 — Availability likely —
Mucus Relief Extended Release Maximum Strength 1200 mg 70000-0479-01 CARDINAL 14 tablets $0.469 — FDA listed +9%
Good Sense Mucus ER 1200 mg 00113-3650-00 L. 14 tablets — — FDA listed —
Good Sense Mucus ER 1200 mg 00113-4077-01 L. 7 tablets — — FDA listed —
Guaifenesin 1200 mg 00363-0033-01 WALGREEN 14 tablets — — FDA listed —
Guaifenesin 1200 mg 00363-0570-27 Walgreens 14 tablets — — FDA listed —
Mucus Relief Extended Release Maximum Strength 1200 mg 00363-0832-14 Walgreens 14 tablets — — FDA listed —
Mucus Relief 1200 mg 00536-1392-88 Rugby 1 tablet — — FDA listed —
Mucus Relief Extended Release 1200 mg 11673-0732-14 TARGET 14 tablets — — FDA listed —
Guaifenesin 1200 mg 11673-0840-27 TARGET 14 tablets — — FDA listed —
Guaifenesin 1200 mg 11822-4260-01 RITE 14 tablets — — FDA listed —
Mucus Relief Max 1200 mg 21130-0399-01 Better 14 tablets — — FDA listed —
Guaifenesin 1200 mg 21130-0554-27 Safeway, 14 tablets — — FDA listed —
Guaifenesin 1200 mg 25000-0041-12 MARKSANS 500 tablets — — FDA listed —
Guaifenesin Extended Release 1200 mg 30142-0962-14 Kroger 14 tablets — — FDA listed —
Mucus Relief Maximum Strength 1200 mg 36800-0932-14 TOP 14 tablets — — Discontinued —
Mucus Relief Extended Release Maximum Strength 1200 mg 37808-0762-14 H 14 tablets — — FDA listed —
Mucus Relief 1200 mg 37835-0412-28 Bi-Mart 28 tablets — — FDA listed —
Maximum Strength Mucus Relief 1200 mg 41226-0724-89 KROGER 14 tablets — — FDA listed —
mucus relief 1200 mg 41250-0654-02 Meijer 14 tablets — — Discontinued —
Guaifenesin Extended Release 1200 mg 41415-0997-14 PUBLIX 14 tablets — — FDA listed —
Mucus Relief Maximum Strength 1200 mg 41520-0732-14 Care 14 tablets — — FDA listed —
mucus er 1200 mg 42507-0471-14 HyVee 7 tablets — — FDA listed —
Guaifenesin 1200 mg 43598-0009-25 Dr. 14 tablets — — FDA listed —
Guaifenesin 1200 mg 43598-0108-37 Dr. 14 tablets — — FDA listed —
Equate Mucus Relief 1200 mg 49035-0284-48 Wal-Mart 48 tablets — — FDA listed —
Guaifenesin Extended Release 1200 mg 49483-0724-70 TIME 70 tablets — — FDA listed —
Mucinex Maximum Strength 1200 mg 50090-2301-00 A-S 7 tablets — — Discontinued —
mucus extended release 1200 mg 51316-0400-55 CVS 7 tablets — — FDA listed —
Mucus And Chest Congestion 1200 mg 51316-0520-74 CVS 7 tablets — — FDA listed —
Mucus Relief 1200 mg 51316-0724-94 CVS 14 tablets — — FDA listed —
mucus relief 1200 mg 51316-0728-74 CVS 7 tablets — — FDA listed —
Guaifenesin 1200 mg 51660-0567-54 Ohm 14 tablets — — FDA listed —
Mucus Relief Maximum Strength 1200 mg 53041-0191-48 Guardian 7 tablets — — FDA listed —
Guaifenesin Extended-Release 1200 mg 53041-0234-37 Guardian 7 tablets — — FDA listed —
Mucus Relief Maximum Strength 1200 mg 53942-0204-02 Demoulas 14 tablets — — FDA listed —
Mucus Relief Max 1200 mg 53943-0234-07 Discount 14 tablets — — FDA listed —
Mucus Relief 1200 mg 55319-0551-07 Family 1 tablet — — FDA listed —
Mucus Relief 1200 mg 55319-0733-14 Family 1 tablet — — FDA listed —
dg health mucus er max 1200 mg 55910-0626-74 Dolgencorp 14 tablets — — FDA listed —
DG health mucus er max 1200 mg 55910-0887-74 Dolgencorp 7 tablets — — FDA listed —
Crcle Guaifensin Extended Release Tablet, 1200 mg 57483-0280-02 Innovus 56 tablets — — FDA listed —
Giltuss EX Maximum Strength Expectorant 1200 mg 58552-0341-07 Gil 7 tablets — — FDA listed —
Guaifenesin 1200 mg 58602-0811-01 Aurohealth 14 tablets — — FDA listed —
Guaifenesin 1200 mg 58602-0865-03 Aurohealth 14 tablets — — FDA listed —
Mucus Relief 1200 mg 59726-0237-07 P 1 tablet — — FDA listed —
Mucus Relief 1200 mg 61504-0204-02 AMERIFOODS 14 tablets — — FDA listed —
Guaifenesin 1200 mg 62207-0569-93 Granules 2000 tablets — — FDA listed —
Guaifenesin 1200 mg 62207-0840-71 Granules 10 tablets — — FDA listed —
Mucinex Maximum Strength 1200 mg 63824-0023-02 Reckitt 1 tablet — — FDA listed —
Maximum Strength Mucus Relief 1200 mg 63868-0148-14 CHAIN 7 tablets — — FDA listed —
Guaifenesin 1200 mg 65162-0037-03 Amneal 30 tablets — — FDA listed —
Mucus Relief Maximum Strength 1200 mg 67091-0404-02 WINCO 7 tablets — — FDA listed —
Maximum Strength Mucus Relief 1200 mg 68196-0033-56 SAM'S 14 tablets — — FDA listed —
Guaifenesin 1200 mg 68196-0405-14 SAM'S 56 tablets — — FDA listed —
Guaifenesin 1200 mg 68196-0960-56 Sam's 14 tablets — — FDA listed —
Guaifenesin Extended Release 1200 mg 68196-0996-56 SAM'S 14 tablets — — FDA listed —
berkley and jensen mucus relief 1200 mg 68391-0000-45 BJWC 14 tablets — — FDA listed —
Mucus Relief 1200 mg 68391-0724-95 BJWC 84 tablets — — FDA listed —
Mucus Relief Maximum Strength 1200 mg 69168-0460-32 Allegiant 100 tablets — — FDA listed —
Guaifenesin 1200 mg 69842-0335-16 CVS 14 tablets — — FDA listed —
Mucus Relief Extended Release Maximum Strength 1200 mg 69842-0732-14 CVS 14 tablets — — FDA listed —
Guaifenesin 1200 mg 69848-0018-16 GRANULES 14 tablets — — FDA listed —
Guaifenesin 1200 mg 71309-0461-56 Safrel 56 tablets — — FDA listed —
Mucus Relief Maximum Strength 1200 mg 72036-0204-02 HARRIS 14 tablets — — FDA listed —
Mucus Relief 1200 mg 72090-0012-01 Pioneer 100 tablets — — FDA listed —
basic care mucus er max 1200 mg 72288-0613-55 Amazon.com 7 tablets — — FDA listed —
basic care mucus er max 1200 mg 72288-0650-02 Amazon.com 14 tablets — — FDA listed —
Curist Mucus Relief Maximum Strength 1200 mg 72559-0013-11 Little 14 tablets — — FDA listed —
MUCUS RELIEF GUAIFENESIN EXTENDED-RELEASE 1200 mg 73581-0402-01 YYBA 100 tablets — — FDA listed —
Guaifenesin 1200 mg 76162-0031-56 TOPCO 14 tablets — — FDA listed —
Topcare Mucus ER 1200 mg 76162-0409-01 Topco 7 tablets — — FDA listed —
Topcare Mucus ER 1200 mg 76162-0523-01 Topco 14 tablets — — FDA listed —
Mucus Relief 1200 mg 79481-1204-01 Meijer 14 tablets — — FDA listed —
equate mucus relief 1200 mg 79903-0327-14 WALMART 7 tablets — — FDA listed —
Betr chest congestion relief 1200 mg 80267-0002-74 Live 14 tablets — — FDA listed —
Betr remedies chest congestion relief 1200 mg 80267-0010-74 Live 1 tablet — — FDA listed —
Guaifenesin 1200 mg 80513-0413-11 Advanced 110 tablets — — FDA listed —
Expectorant Guaifenesin Extended-Release 1200 mg 81179-0007-04 YET 70 tablets — — FDA listed —
Mucus Relief 1200 mg 81522-0204-02 FSA 14 tablets — — FDA listed —
Up And Up Mucus Relief 1200 mg 82442-0503-01 Target 7 tablets — — FDA listed —
Guaifenesin - Odaat 1200 Mg 83139-0175-01 LODAAT 100 tablets — — FDA listed —
Mucus Relief 1200 mg 84324-0034-01 NUVICARE 24 tablets — — FDA listed —
Dr Simi Mucus Relief Expectorant 1200 mg 85786-0301-14 Farmacias 14 tablets — — FDA listed —
Guaifenesin 1200 mg 71179-0002-21 VESPYR 7 tablets — — FDA listed —
Guaifenesin 1200 mg 58602-0857-93 Aurohealth 14 tablets — — FDA listed —
Mucus Relief 1200 mg 73581-0403-01 YYBA 100 tablets — — FDA listed —
Maximum Strength Mucus Relief 1200 mg 70677-1320-01 Strategic 14 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Jun 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color Blue
ShapeOval
ImprintL4S1
Size22 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII HHT01ZNK31
    Carbomer Homopolymer Type B is a synthetic polymer made from acrylic acid. It absorbs water and forms a gel, so it's used in medicines as a thickener, suspending agent, and to help create a smooth texture in creams, gels, and lotions.
  • UNII D9C330MD8B
    Copovidone is a synthetic polymer made by combining two types of plastic-like molecules. It acts as a binder and film-former to help hold tablet ingredients together and improve how the medicine dissolves in your body.
  • UNII J9EQA3S2JM
    FD&C Blue No. 1 Aluminum Lake is a blue colorant made by combining FD&C Blue No. 1 dye with aluminum salts. It is used to color tablets, capsules, and other medicines for easy identification and appearance.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII H8AV0SQX4D
    A modified starch derived from potato or corn starch. It absorbs water quickly and helps tablets or capsules break apart and dissolve in the stomach, acting as a disintegrant to ensure the medicine releases its active ingredients properly.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarbomer homopolymer type B, copovidone, FD&C blue #1 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium starch glycolate

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerisource Bergen
Application holderPERRIGO R AND D CO
FDA applicationANDA078912 (ANDA)
Labeler code46122
First marketedJun 2025
Product typeHuman Otc Drug
Portfolio206 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 23 words ▾

Uses • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

⏱️ Dosage and Administration 65 words ▾

Directions • do not crush, chew, or break extended-release tablet • take with a full glass of water • this product can be administered without regard for timing of meals • adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed 2 extended-release tablets in 24 hours. • children under 12 years of age: do not use

⚠️ Warnings 107 words ▾

Warnings Do not use • for children under 12 years of age Ask a doctor before use if you have • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema • cough accompanied by too much phlegm (mucus) Stop use and ask a doctor if • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

🧪 Active Ingredient 9 words ▾

Active ingredient (in each extended-release tablet) Guaifenesin 1200 mg

🧪 Inactive Ingredients 22 words ▾

Inactive ingredients carbomer homopolymer type B, copovidone, FD&C blue #1 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, silicon dioxide, sodium starch glycolate

🎯 Purpose 2 words ▾

Purpose Expectorant

📄 Do Not Use 11 words ▾

Do not use • for children under 12 years of age

📄 Ask a Doctor Before Use If 31 words ▾

Ask a doctor before use if you have • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema • cough accompanied by too much phlegm (mucus)

📄 Stop Use and Ask a Doctor If 32 words ▾

Stop use and ask a doctor if • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Other Information 7 words ▾

Other information • store at 20-25°C (68-77°F)

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-719-9260

📄 Package Label / Principal Display Panel 53 words ▾

Package/Label Principal Display Panel Compare to Maximum Strength Mucinex ® active ingredient GOOD NEIGHBOR PHARMACY ® 12 HOUR Maximum Strength Mucus ● ER guaifenesin extended-release tablets, 1200 mg / expectorant Relieves Chest Congestion • Relieves Chest Congestion • Thins and Loosens Mucus • Immediate and Extended Release actual size 14 Extended-Release Tablets mucus-er

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q3 2025 – Q1 2026 · 3 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
323
Units reimbursed last 4 qtrs
8.2K
Gross reimbursed last 4 qtrs
$6.4K
Avg / prescription
$19.68
Avg / unit
$0.7769
Latest quarter Q1 2026
123Rx
Medicaid pays / ea
$0.7769
gross reimbursed
vs
NADAC / ea
$0.4316
acquisition cost
=
Spread
+$0.3453
+80% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
31% FFS 69% MCO
Fee-for-service · 101 Rx Managed care · 222 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 2,696 units · 13.8 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 294 units · 4.3 per 100k residents IN Ohio: 1,140 units · 9.7 per 100k residents OH Pennsylvania: 1,180 units · 9.1 per 100k residents PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 2,872 units · 63.5 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.363.5
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 63.5 /100k
2 New York 13.8 /100k
3 Ohio 9.7 /100k
4 Pennsylvania 9.1 /100k
5 Indiana 4.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Good Neighbor Pharmacy Mucus ER (this brand).

Top reported reactions

Dyspnoea561
Pneumonia528
Nausea479
Fatigue450
Pain423
Diarrhoea402
Cough368

Reporter sex

0 reports
Male · 42%
Female · 57%
Unknown · 0%

Serious outcomes

Death917
Disabling195
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 591 217
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 46122-0813-29 · Amerisource 46122-0815-64 · AMERISOURCE →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.